
Orally delivered drugs in clinical trials for DR: looking into the future
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, laser panretinal photocoagulation and intravitreal corticosteroid implants are clinically used to resolve diabetic macular oedema (DMO), the most common cause of vision loss in diabetic retinopathy (DR) patients.
9 min read

